Elevated platelet-monocyte complexes in patients with psoriatic arthritis

Area of Science:

• Cardiovascular Research
• Immunology
• Rheumatology

Background:

• Psoriatic arthritis (PsA) is linked to endothelial dysfunction and atherosclerosis.
• Platelet and endothelial activation are implicated in inflammatory conditions.

Purpose of the Study:

• To evaluate platelet and endothelial activation markers in psoriatic arthritis (PsA).
• To explore the association between these markers and disease characteristics.

Main Methods:

• Flow cytometry was used to measure platelet-monocyte complexes (PMC), platelet-neutrophil complexes (PNC), and P-selectin expression.
• ELISA determined soluble E-selectin (sE-selectin) and soluble CD40L (sCD40L) levels.
• Clinical and acute phase parameters were assessed in 20 PsA patients, 8 psoriasis patients, and 20 controls.

Main Results:

• PMC levels were significantly higher in PsA patients compared to controls (p=0.02).
• sE-selectin levels were elevated in both PsA and psoriasis groups versus healthy controls (p<0.001, p=0.023).
• Higher sCD40L was observed in polyarticular and active PsA, correlating with C-reactive protein (CRP).

Conclusions:

• Endothelial activation may contribute to the pathogenesis of psoriasis and PsA.
• Platelet activation, specifically PMC, might play a role in PsA pathogenesis.
• sE-selectin indicates endothelial activation in PsA and psoriasis.